Similar Papers

Paper Title
Journal
Date
Author
Interleukin-21 enhances T-helper cell type I signaling and interferon-γ production in Crohn’s disease
Giovanni Monteleone ... Francesco Pallone
Gastroenterology | VOL. 128
Giovanni Monteleone, et. al.Giovanni Monteleone ... Francesco Pallone
01 Mar 2005
A Functional Role of Flip in Conferring Resistance of Crohn’s Disease Lamina Propria Lymphocytes to FAS-Mediated Apoptosis
Ivan Monteleone ... Francesco Pallone
Gastroenterology | VOL. 130
Ivan Monteleone, et. al.Ivan Monteleone ... Francesco Pallone
01 Feb 2006
Gut permeability to lactulose and mannitol differs in treated Crohn's disease and celiac disease patients and healthy subjects
E.G Vilela ... H.O.G Torres
Brazilian Journal of Medical and Biological Research | VOL. 41
E.G Vilela, et. al.E.G Vilela ... H.O.G Torres
01 Dec 2008
S0724 Characteristics of Crohn's Disease Patients in the Corrona Inflammatory Bowel Disease Registry on Biological or Conventional Therapy Differ by Disease Duration
Bincy P Abraham ... April N Naegeli
American Journal of Gastroenterology | VOL. 115
Bincy P Abraham, et. al.Bincy P Abraham ... April N Naegeli
01 Oct 2020
View more papers

More From: Journal of Crohn's and Colitis

Paper Title
Journal
Date
Author
P0293 The utility of small bowel capsule endoscopy in Crohn’s Disease – a retrospective cohort study
J H Yeo ... I Parisi
Journal of Crohn's and Colitis | VOL. 19
J H Yeo, et. al.J H Yeo ... I Parisi
22 Jan 2025
P0755 Long-term safety of subcutaneous vedolizumab in Ulcerative Colitis and Crohn’s disease: Findings from the VISIBLE OLE study
S Vermeire ... G D’Haens
Journal of Crohn's and Colitis | VOL. 19
S Vermeire, et. al.S Vermeire ... G D’Haens
22 Jan 2025
P0195 Immune reconstitution following autologous hematopoietic stem cell transplantation with cyclophosphamide-free mobilization for refractory Crohn’s disease
E Saager ... H Fidder
Journal of Crohn's and Colitis | VOL. 19
E Saager, et. al.E Saager ... H Fidder
22 Jan 2025
P0586 Nationwide population-based cohort study on the use and persistence of infliximab (IV and SC) in France: the Riposte IBD study
J Kirchgesner ... C Prati
Journal of Crohn's and Colitis | VOL. 19
J Kirchgesner, et. al.J Kirchgesner ... C Prati
22 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.